The company
Rapid Micro Biosystems, Inc.
RPID · Nasdaq
RPID stood above a rising 150-day average in 12 of the last 52 weekly readings, and has been out of that trend for the last 32 weeks. It is 58.4% below that average now. Life Science Tools & Research Services: 52% of its 79 stocks in an uptrend (+4 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 32
- Industry in uptrend
- 52% +4 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $2.3M
- Officials’ trades on record
- 0
- Institutions holding
- 33 (-10)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 12 of 52 weeks.
Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Bain Capital Life Sciences Investors, Llc10% owner | bought | 1,463,000 | 20 May 2026filed 22 May 2026 |
| Bain Capital Life Sciences Investors, Llc10% owner | bought | 1,463,000 | 20 May 2026filed 22 May 2026 |
| Bain Capital Life Sciences Investors, Llc10% owner | bought | 1,463,000 | 20 May 2026filed 22 May 2026 |
| Sean M. WirtjesCHIEF FINANCIAL OFFICER | sold | 7,480at $4.32 | 11 Mar 2026filed 12 Mar 2026 |
| John J. Addington WilsonCHIEF OPERATING OFFICER | sold | 9,603at $4.32 | 11 Mar 2026filed 12 Mar 2026 |
| Robert G. Spignesi, Jr.PRESIDENT AND CEO | sold | 17,922at $4.11 | 10 Mar 2026filed 12 Mar 2026 |
| Sean M. WirtjesCHIEF FINANCIAL OFFICER | sold | 17,254at $3.92 | 20 Feb 2026filed 20 Feb 2026 |
| John J. Addington WilsonCHIEF OPERATING OFFICER | sold | 5,403at $3.92 | 20 Feb 2026filed 20 Feb 2026 |
| Robert G. Spignesi, Jr.PRESIDENT AND CEO | sold | 38,327at $3.89 | 19 Feb 2026filed 20 Feb 2026 |
| Sean M. WirtjesCHIEF FINANCIAL OFFICER | sold | 6,027at $3.78 | 9 Feb 2026filed 10 Feb 2026 |
| Robert G. Spignesi, Jr.PRESIDENT AND CEO | sold | 12,840at $3.78 | 9 Feb 2026filed 10 Feb 2026 |
| John J. Addington WilsonCHIEF OPERATING OFFICER | sold | 4,610at $3.78 | 9 Feb 2026filed 10 Feb 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Bain Capital Life Sciences Investors, LLCunchanged · filed 14 Aug 2026 | 8,434,560$14.6M | 00.0% |
| ARMISTICE CAPITAL, LLCnew · filed 14 Aug 2026 | 3,328,000$5.8M | +3,328,000 |
| ABG-WTT Global Life Science Capital Partners GP Ltdunchanged · filed 14 Aug 2026 | 1,848,296$3.2M | 00.0% |
| VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026 | 982,034$1.7M | -4600.0% |
| Evernest Financial Advisors, LLCadded · filed 6 Aug 2026 | 506,000$875K | +73,490+17.0% |
| Advent International, L.P.reduced · filed 14 Aug 2026 | 379,794$657K | -172,583−31.2% |
| ESSEX INVESTMENT MANAGEMENT CO LLCreduced · filed 6 Aug 2026 | 362,696$627K | -521,235−59.0% |
| MILLENNIUM MANAGEMENT LLCreduced · filed 14 Aug 2026 | 236,599$409K | -46,681−16.5% |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 228,041$395K | -19,136−7.7% |
| RENAISSANCE TECHNOLOGIES LLCadded · filed 13 Aug 2026 | 212,101$367K | +85,484+67.5% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.